some concerns there re petracker and sentia sales but given management have been forthright and delivered on timelines generally speaking i am satisified with the update and prepared to trust them.
Seems their technology is able to be adapted relatively quickly and easily to alternative uses ie see the fructose/liver development, considering seriously loading up as i think this has lot of potential to explode and become great dividend and capital growth play. interested in how others view, seems to me reasonably stable bet now with massive upside and not much downside at this price
Ann: Half Year Results Presentation - 30 June 2024, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.015(10.7%) |
Mkt cap ! $37.25M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $61.45K | 469.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 57870 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 104965 | 2 |
View Market Depth
| Last trade - 14.46pm 12/09/2024 (20 minute delay) ? |
| UBI (ASX) Chart |